MRNA · Moderna, Inc.

$67.272026-07-21

Sector: Healthcare; Industry: Biotechnology; Sub-Industry: Biotechnology

Intrinsic Value Range Comparison · Mulya.ai

Leases factored

Bull

$0

-32937.2% vs market

Base · active

$0

-28501.6% vs market

Bear

$0

-1517.0% vs market

Mulya.ai vs Analyst IV Comparison?

Bear $-953

Base $-19106

Bull $-22090

Median $42

Market $67

Market Price $67

Mulya.ai Base $-19106

Analysts Median $42

Mulya.ai IV range ($-953 · $-22090)

Analysts Range ($33 · $77)

Fundamentals · historical + forward · base

italics = DCF projection

Period	Revenue	Rev Gr ?	Ops M% ?	Tax Rate ?	NOPAT ?	Reinvest ?	FCFF ?	WACC% ?	PV FCFF ?	ROIC ?	Inv. Cap ?	EPS ?	P/E
2024.Q1	$6.8B	—	-61.9%	0.0%	−$5.3B	$330MM	−$4.9B	8.6%	—	-108.8%	$4.8B	$-11.93	—
2024.Q4	$6.8B	0.0%	-61.9%	1.3%	−$4.2B	$351MM	−$3.8B	10.3%	—	-90.2%	$4.4B	$-11.93	—
2025.Q1	$3.2B	-53.3%	-123.3%	1.4%	−$3.9B	$188MM	−$3.7B	9.1%	—	-85.8%	$4.6B	$-9.02	—
2025.Q4	$3.2B	0.0%	-123.3%	0.0%	−$4.0B	−$340MM	−$4.4B	10.4%	—	-87.4%	$4.6B	$-9.02	—
2026.Q1	$2.2B	-30.4%	-150.8%	0.0%	−$3.4B	$627MM	−$2.8B	9.0%	—	-87.1%	$3.3B	$-8.09	—
italics below = DCF projection · 10yr Rev CAGR: 20.6%
2027.Q1	$2.2B	+-2.2%	-8979.5%	2.0%	−$191.5B	$0MM	−$191.5B	8.0%	−$177.3B	-5864.5%	$3.3B	$-1.42	—
2028.Q1	$2.6B	+21.1%	-8979.5%	4.0%	−$227.2B	−$39MM	−$227.2B	8.0%	−$194.8B	-6917.0%	$3.3B	$-1.68	—
2029.Q1	$3.6B	+35.5%	-8979.5%	6.0%	−$301.5B	−$151MM	−$301.7B	8.1%	−$239.2B	-8922.5%	$3.5B	$-2.23	—
2030.Q1	$5.5B	+54.4%	-8979.5%	8.0%	−$455.6B	−$3.5B	−$459.0B	8.2%	−$336.6B	-8782.2%	$6.9B	$-3.37	—
2031.Q1	$7.3B	+31.5%	-8979.5%	10.0%	−$586.2B	−$2.8B	−$589.0B	8.2%	−$399.1B	-7042.5%	$9.7B	$-4.33	—

Term. Yr+	$15.1B	4.1%	-8936.0%	20.0%	−$1077.0B	$513.5B	−$563.6B	8.6%	−$5665.9B	8.6%	—	—	—

Active scenario IV: $0 (-28501.6% vs market)